Introduction. With increasing life expectancy, more women with cystic fibrosis and diabetes mellitus become pregnant. We investigated how pre-gestational diabetes (cystic fibrosis-related diabetes) influenced pregnancy outcome and the clinical status of these women. Material and methods. We analyzed all pregnancies reported to the French cystic fibrosis registry between 2001 and 2012, and compared forced expiratory volume (FEV 1 ) and body mass index before and after pregnancy in women with and without pre-gestational diabetes having a first delivery. Results. A total 249 women delivered 314 infants. Among these, 189 women had a first delivery and 29 of these had pregestational diabetes. There was a trend towards a higher rate of assisted conception among diabetic women (53.8%) than non-diabetic women (34.5%, p = 0.06), and the rate of cesarean section was significantly higher in diabetic women (48% vs. 21.4%, p = 0.005). The rate of preterm birth and mean infant birthweight did not differ significantly between diabetic and non-diabetic women. Forced expiratory volume before pregnancy was significantly lower in the diabetic group. The decline in forced expiratory volume and body mass index following pregnancy did not differ between the women with and those without pre-gestational diabetes. Conclusion. Pre-gestational diabetes in women with cystic fibrosis is associated with a higher rate of cesarean section but does not seem to have a clinically significant impact on fetal growth or preterm delivery. The changes in maternal pulmonary and nutritional status following pregnancy in women with cystic fibrosis were not influenced by pre-gestational diabetes.
Introduction
There have been substantial advances in care for individuals with cystic fibrosis (CF). Women with CF are now likely to survive into adulthood [the median predicted survival is around 40 years in Europe (1)] and therefore young women with CF have typical expectations for their reproductive health. The number of pregnancies in these women has consequently increased in most countries (2) , and pregnancy is no longer considered to have a negative impact on survival of CF women (3) (4) (5) (6) . Increased life expectancy has, however, also led to diabetes becoming a common complication in CF, affecting up to half of those aged 30 years and older (7) . Diabetes in CF is considered a risk factor for clinical degradation and it is associated with more severe pulmonary disease, more frequent pulmonary exacerbations, and poorer nutritional status (7) .
Most authors who have investigated pregnancies in CF have done so by comparing pregnant and non-pregnant CF women without taking into account known risk factors for poorer outcomes in such patients (3) (4) (5) (6) (8) (9) (10) (11) . It is also of note that CF women have an increased likelihood of receiving treatment for diabetes both during and after pregnancy (12) , which could be related to the overall improvement in survival of young CF women. However, the specific risk to pregnancies and maternal health status associated with pre-pregnancy cystic fibrosisrelated diabetes (CFRD) has not been established. The aim of the present study was therefore to compare pregnancy outcome and clinical decline in CF women having a first pregnancy leading to birth included in the French CF registry according to their diabetic status before pregnancy.
Material and methods

Study population and setting
A multicenter observational study was conducted using data from the French CF registry in which pregnancies in CF women attending one of the 49 French CF care centers are recorded.
We included all pregnancies registered between 1 January 2001 and 31 December 2012 irrespective of pregnancy outcome (miscarriages, induced abortion for medical reasons, voluntary interruption). Pregnancies in women who had received a pulmonary transplantation before pregnancy were excluded.
For comparison between diabetic and non-diabetic women, we analyzed only those with a first pregnancy leading to birth between 1 January 2001 and 31 December 2012, and with a two-year follow up after delivery without a second pregnancy. We considered for each woman a study period of four consecutive years starting the year before pregnancy until two years after pregnancy; the maximum observational study period was therefore the years 2000-014.
Collected data from the French CF registry Data in the French CF registry is completed annually for each patient. Data extracted for the present study included forced expiratory volume in one-second (FEV 1 ) (best value of the year) and body mass index (BMI; value measured at the time of best FEV 1 ), assisted conception, mode of delivery (vaginal or cesarean section), and prematurity, as well as newborn birthweight and CF status. The outcome of pregnancy was defined as preterm birth in case of birth before 37 weeks' gestational age.
Outcome measures
Cystic fibrosis women were categorized according to their diabetic status before pregnancy. The outcome measures were rate of FEV 1 and BMI decline during the follow-up period. The FEV 1 and BMI values used were those annually collected in the registry. Analyses compared CF women with pre-pregnancy diabetes to CF women without pre-pregnancy diabetes.
Statistical analyses
Descriptive data are presented as median with range and number of available data. For comparisons between groups, the Chi-square or Fisher's test was used, including Wilcoxon's test for quantitative variables. Variations in the FEV 1 and BMI observed during follow up in each group were also compared. To assess the potential effect of diabetes on FEV 1 and BMI, a linear regression was used to estimate the rate of change in FEV 1 and BMI decline during the four-year period of follow up . The Wilcoxon test was used to compare the median rate of FEV1 and BMI decline. All analyses were performed using SAS software version 9.3 (SAS Institute; Cary, NC, USA). All p-values reported are two-tailed; values <0.05 were considered statistically significant.
Ethical approval
According to the current French legislation, demographic and clinical data were extracted from the French CF registry with permission from the institutional review board (CCTIRS, registration number 10536, 3 December 2015) and from the national data protection commission (Commission Nationale de l'Informatique et des Libert es. DR number 1202233/February 2016).
Key Message
Pre-pregnancy diabetes in women with cystic fibrosis is not associated with an increased risk of deterioration of maternal pulmonary or nutritional status.
Results
Pregnancies in the CF French registry between 2001 and 2012
Between 2001 and 2012, 294 pregnancies in 232 women were reported in the French CF Registry. There were 180 women who had one pregnancy, 42 women had two, and 10 who had three; 234 births in all. Median (range) age at pregnancy was 27 years (15-42) and 37.3% of women were homozygous for the F508del mutation, 79.8% had pancreatic insufficiency, and 3.6% received chronic enteral feeding. At initiation of the follow-up period, median (range) FEV 1 was 65.0% (18.9-131.5) and the median (range) BMI was 20.2 kg/m 2 (14.9-34.2). Of the 234 births, 62.6% of pregnancies were spontaneous, 70.3% of pregnancies ended in a term-delivery, and delivery was by cesarean section in 26.7% of cases. None of the newborns died. Median (range) weight at birth was 3000 g (650-3990). CF was diagnosed in three children. There were 16 cases of therapeutic termination, 13 cases of voluntary abortion, 29 miscarriages, and two cases for which data were not available.
Comparative analysis according to diabetic status before first pregnancy
Considering only the first pregnancies leading to birth and with a two-year follow up after delivery without a second pregnancy, 189 pregnancies were analyzed: 29 (15%) pregnancies occurred in diabetic women and 160 (85%) in non-diabetic women. Nine women received transplantation more than two years after pregnancy; among them, two were diabetic the year before pregnancy.
The main characteristics of diabetic and non-diabetic groups the year of pregnancy are described in Table 1 . There was a non-significant trend towards a higher rate of assisted conception in diabetic women than non-diabetic women (p = 0.06). The rate of cesarean section was significantly higher in diabetic women (p = 0.005). There was no significant difference in the rate of premature births between the groups. Diabetic women were older (p = 0.05). The median FEV 1 was significantly lower in diabetic women (p = 0.03), and the median BMI of diabetic and non-diabetic women was not significantly different (p = 0.55). There was also no significant difference in the change in BMI between groups over the same period [À0.37 (À3.32 to 2.67) and 0.30 (À4.17 to 5.98)] (p = 0.62; Figure 2 ). Median (range) BMI of diabetic and non-diabetic women at YÀ1 was 19.9 (16.9-25.9) and 20.2 (15.1-34.1), the year of pregnancy it was 19.9 (17.0-26.7) and 21.1 (13.0-37.0), at Y+1 it was 19.6 (16.9-26.6) and 20.6 (14.2-34.4), and at Y+2 it was 19.1 (14.9-25.7) and 19.9 (14.2-34.4), respectively.
Discussion
The present study found that CFRD in pregnant French women was associated with higher risk of cesarean section rate and a trend in more frequent use of assisted conception techniques. There was no significant deleterious effect of CFRD on FEV 1 or BMI decline over the study period.
Herein, cesarean section delivery was more frequent among those with diabetes than those without diabetes, as has been described in diabetic women among the general population (13, 14) . Diabetic women had a significantly lower FEV 1 in the year of pregnancy, which might be explained by older age, but their lower FEV 1 did not seem to have a negative impact on lung function after pregnancy, although CFRD has been reported to be associated with this in the general population (7). Diabetic women did not have a poorer nutritional status, as reflected by BMI, possibly because of high treatment burden and surveillance in the case of diabetes. The absence of a higher gestational weight gain in pregnancy in the pregnant women with CFRD than in those without CFRD [19.9 (17.0-26.7) and 21.1 (13.0-37.0), p = 0.36] may be explained by higher energy expenditure related to low FEV1 in diabetic women.
More generally, the absence of a more rapid decline of pulmonary and nutritional status in diabetic women could, at least in part, be related to the early identification and aggressive treatment of diabetes, which has reduced the negative impact of CFRD on CF clinical status (15) . Another explanation could be that pregnancy is now well prepared for by CF women and care providers, leading to optimal preconception care and close monitoring of pulmonary exacerbations and nutritional status according to published guidelines (16) . However, as highlighted by recent studies, reproductive decision making is complex for both young women with CF and care providers, particularly concerning CF women with complicated clinical conditions such as CFRD (17, 18) ; the data reported in the present study provide some information to help the decision making.
The study has some limitations. The most important one is that the size of the diabetic group is small, and even modest differences between the groups may have been missed, as suggested by the data on FEV 1 decline. However, the analysis considered a fairly long follow up for adult women, which was sufficient to observe a clinical impact. Inherent differences in patients who became pregnant and those who did not are likely to exist, and women with a better health status are more inclined to initiate and successfully complete a pregnancy, as demonstrated in a previous study (8) . Registration of diabetes diagnosis in the French registry may have induced bias, as it included both treated and non-treated diabetes. Furthermore, the screening rate for diabetes in CF has also improved since 2001. No specific data regarding diabetes treatment or monitoring during the study period were available. It was also not possible to evaluate the medical and psychological events prior to the pregnancy that may influence patients to choose to become pregnant.
The number of CF women of childbearing age with a good health status is increasing owing to the consistent use of symptomatic CF therapies, and this number will increase further with the arrival of CFTR modulators. Much remains to be done to clarify the impact of diabetes on pregnancies in CF, but this study emphasizes the good prognosis of pregnancies in diabetic CF women. In conclusion, pre-pregnancy diabetes in CF women does not seem to be associated with an increased risk of a decline in maternal clinical status.
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